HomeInsightsStock Comparison

Ami Organics Ltd vs Neuland Laboratories Ltd Stock Comparison

Ami Organics Ltd vs Neuland Laboratories Ltd Stock Comparison

Last Updated on: Jun 24, 2025

Key Highlights

  • The Latest Trading Price of Ami Organics Ltd is ₹ 1097 as of 24 Jun 11:00.
  • The P/E Ratio of Ami Organics Ltd changed from 50.6 on March 2022 to 94.3 on March 2024 . This represents a CAGR of 23.06% over 3 yearsThe P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 27 on March 2024 . This represents a CAGR of 3.71% over 5 years.
  • The Market Cap of Ami Organics Ltd changed from ₹ 3642 crore on March 2022 to ₹ 4036 crore on March 2024 . This represents a CAGR of 3.48% over 3 yearsThe Market Cap of Neuland Laboratories Ltd changed from ₹ 363.66 crore on March 2020 to ₹ 8058 crore on March 2024 . This represents a CAGR of 85.83% over 5 years.
  • The revenue of Ami Organics Ltd for the Mar '25 is ₹ 314.26 crore as compare to the Dec '24 revenue of ₹ 276.66 crore. This represent the growth of 13.59% The revenue of Neuland Laboratories Ltd for the Mar '25 is ₹ 335.82 crore as compare to the Dec '24 revenue of ₹ 457.72 crore. This represent the decline of -26.63%.
  • The ebitda of Ami Organics Ltd for the Mar '25 is ₹ 90.74 crore as compare to the Dec '24 ebitda of ₹ 70.34 crore. This represent the growth of 29% The ebitda of Neuland Laboratories Ltd for the Mar '25 is ₹ 58.54 crore as compare to the Dec '24 ebitda of ₹ 146.28 crore. This represent the decline of -59.98%.
  • The net profit of Ami Organics Ltd changed from ₹ 22.24 crore to ₹ 62.72 crore over 8 quarters. This represents a CAGR of 67.93% The net profit of Neuland Laboratories Ltd changed from ₹ 61.88 crore to ₹ 27.81 crore over 8 quarters. This represents a CAGR of -32.96% .
  • The Dividend Payout of Ami Organics Ltd changed from 15.19 % on March 2022 to 25.33 % on March 2024 . This represents a CAGR of 18.58% over 3 yearsThe Dividend Payout of Neuland Laboratories Ltd changed from 16.25 % on March 2020 to 6.03 % on March 2024 . This represents a CAGR of -17.99% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ami Organics Ltd

  • Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India.
  • The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
  • Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018. The Company is engaged in business of drugs intermediate chemicals and related activities.
  • The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015.

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Ami Organics Ltd News Hub

News

Board of AMI Organics recommends final dividend

AMI Organics announced that the Board of Directors of the Company at its meeting held on 2...

Read more

02 May 2025 14:08

News

Ami Organics jumps after Q4 PAT soars to Rs 627 cr

Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter e...

Read more

02 May 2025 14:49

News

AMI Organics to hold board meeting

AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025. P...

Read more

25 Apr 2025 11:18

News

Ami Organics' Unit II receives Japan PMDA nod for GMP compliance

Ami Organics' manufacturing facility, Unit II situated at Ankleshwar, which is involved in...

Read more

24 Apr 2025 15:57

News

AMI Organics to hold EGM

AMI Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be...

Read more

16 Apr 2025 20:44

News

Board of Ami Organics approves change in company name to Acutaas Chemicals

The Board of Ami Organics at its meeting held on 16 April 2025 has approved the change in ...

Read more

16 Apr 2025 15:03

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories to hold AGM

Neuland Laboratories announced that the 41th Annual General Meeting(AGM) of the company wi...

Read more

17 May 2025 12:57

News

Neuland Labs drops after Q4 PAT slumps 59% YoY to Rs 28 cr

On quarter on quarter (QoQ) basis, the company's net profit declined 72.63% while revenue ...

Read more

16 May 2025 14:51

News

Board of Neuland Laboratories recommends Final Dividend

Neuland Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

15 May 2025 16:52

News

Neuland Laboratories to announce Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

25 Apr 2025 10:43

News

Neuland Laboratories Ltd Spurts 2.02%

Neuland Laboratories Ltd gained 2.02% today to trade at Rs 13000. The BSE Healthcare index...

Read more

17 Apr 2025 09:30

News

Neuland Laboratories appoints Head - Manufacturing

Neuland Laboratories announced that Parag Deshmukh has been appointed as Head - Manufactur...

Read more

10 Mar 2025 15:29

SWOT Analysis Of Ami Organics Ltd

Strength

5

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ami Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Neuland Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ami Organics Ltd and Neuland Laboratories Ltd

Which company has a larger market capitalization, Ami Organics Ltd or Neuland Laboratories Ltd?

Market cap of Ami Organics Ltd is 8,993 Cr while Market cap of Neuland Laboratories Ltd is 15,813 Cr

What are the key factors driving the stock performance of Ami Organics Ltd and Neuland Laboratories Ltd?

The stock performance of Ami Organics Ltd and Neuland Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ami Organics Ltd and Neuland Laboratories Ltd?

As of June 24, 2025, the Ami Organics Ltd stock price is INR ₹1098.55. On the other hand, Neuland Laboratories Ltd stock price is INR ₹12325.15.

How do dividend payouts of Ami Organics Ltd and Neuland Laboratories Ltd compare?

To compare the dividend payouts of Ami Organics Ltd and Neuland Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions